DER2.2 Antibody

What is DER2.2 and what is the target of DER2.2 Antibody?

DER2.2 is a protein from Zea mays (Maize) with UniProt Number Q4G2J3 and Entrez Gene ID 606472 . The DER2.2 Antibody specifically targets this maize protein and is designed for research applications. It's important to note that this should not be confused with Der p 2 (from house dust mite Dermatophagoides pteronyssinus), which is an allergen protein studied in allergy research .

What are the validated applications for DER2.2 Antibody?

According to the product information, DER2.2 Antibody has been validated for ELISA and Western Blot (WB) applications . When planning experiments, researchers should consider that validation ensures the antibody can specifically identify the target antigen in these particular applications. Additional applications may require further validation by the researcher.

What are the source and specifications of commercially available DER2.2 Antibody?

The commercially available DER2.2 Antibody is:

• Raised in rabbit (polyclonal)

• Purified using Protein A/G affinity purification

• Supplied in a storage buffer containing 50% Glycerol, 0.01M PBS (pH 7.4) with 0.03% Proclin 300 as preservative

• Available as a non-conjugated antibody

• Requires storage at -20°C or -80°C to maintain stability

What controls should be included when using DER2.2 Antibody for experimental validation?

Based on standard immunoassay practices similar to those described for other antibodies , proper experimental controls should include:

• Positive control: Recombinant DER2.2 protein can serve as the positive control, which may be provided with the antibody

• Negative control: Pre-immune serum from the same animal is useful for establishing baseline

• Isotype control: Non-specific rabbit IgG at matching concentration

• Sample controls: When possible, include samples with known varying expression levels

• Loading controls: For Western blots, include housekeeping proteins for normalization

What is the recommended protocol for using DER2.2 Antibody in Western blot procedures?

While specific protocols for DER2.2 Antibody might vary, a general Western blot procedure based on standard practices would include:

• Sample preparation: Extract proteins from plant tissue using appropriate buffer with protease inhibitors

• Protein separation: Run 10-50 μg total protein on SDS-PAGE (10-12%)

• Transfer: Transfer proteins to PVDF or nitrocellulose membrane

• Blocking: Block with 5% non-fat milk in TBST for 1 hour at room temperature

• Primary antibody: Dilute DER2.2 Antibody (typically 1:1000, but optimize) in blocking solution and incubate overnight at 4°C

• Washing: Wash 3-5 times with TBST

• Secondary antibody: Incubate with HRP-conjugated anti-rabbit IgG (typically 1:5000) for 1 hour

• Detection: Develop using ECL substrate and appropriate imaging system

Similar to approaches used in other antibody validation studies , optimization of antibody concentration and incubation conditions is crucial for obtaining specific signals.

How can cross-reactivity with other plant proteins be assessed when using DER2.2 Antibody?

Based on methods used for antibody validation in other systems , cross-reactivity assessment should include:

• Sequence homology analysis: Compare DER2.2 sequence with related plant proteins to identify potential cross-reactive epitopes

• Multi-species testing: Test the antibody against proteins from related plant species

• Peptide competition assay: Pre-incubate the antibody with immunizing peptide/protein before application

• Knockout/knockdown controls: When available, test samples from plants with reduced DER2.2 expression

• Mass spectrometry validation: Confirm the identity of immunoprecipitated proteins

What considerations should be made when designing immunoprecipitation experiments with DER2.2 Antibody?

For immunoprecipitation experiments, researchers should consider approaches similar to those used in other antibody-based studies :

• Buffer optimization: Test different lysis and washing buffers to maintain protein-protein interactions while minimizing non-specific binding

• Antibody coupling: Consider covalently coupling the antibody to beads to prevent co-elution during analysis

• Pre-clearing samples: Remove proteins that bind non-specifically to the beads

• Controls: Include IgG control, input sample, and when possible, samples without target protein

• Elution conditions: Optimize elution conditions to efficiently release the target protein while maintaining any interacting partners

• Confirmation: Verify successful immunoprecipitation by Western blot before proceeding to mass spectrometry or other downstream analyses

How can DER2.2 Antibody be used to study protein expression changes in response to environmental stressors in maize?

Building on methodologies used in antibody-based expression studies , researchers can:

• Design time-course experiments: Monitor DER2.2 protein levels at different time points after stress application

• Combine with transcript analysis: Correlate protein levels with mRNA expression using RT-qPCR

• Quantitative Western blotting: Use digital imaging and analysis software for precise quantification

• ELISA-based quantification: Develop a quantitative ELISA using the DER2.2 Antibody for high-throughput analysis

• Tissue-specific analysis: Compare expression across different plant tissues to identify tissue-specific responses

• Subcellular localization: Combine with fractionation techniques to assess potential stress-induced changes in localization

What are the challenges in obtaining consistent results with plant antibodies like DER2.2 Antibody?

Based on challenges documented in other plant and antibody research , researchers should be aware of:

• Plant-specific interfering compounds: Secondary metabolites, phenolics, and polysaccharides can interfere with antibody binding

• Sample preparation variability: Different extraction methods can affect protein yield and epitope accessibility

• Post-translational modifications: These may vary under different conditions and affect antibody recognition

• Antibody batch variation: Particularly relevant for polyclonal antibodies, which may show batch-to-batch differences

• Species specificity: Confirm cross-reactivity if studying DER2.2 homologs in other plant species

Solutions include optimizing extraction buffers with additives like PVPP for phenolics removal, standardizing extraction protocols, and validating each new antibody batch.

How should DER2.2 Antibody detection data be quantified for publication-quality results?

For robust quantification of immunoblot or ELISA data, researchers should follow approaches used in other antibody studies :

• Technical replicates: Include at least three technical replicates per biological sample

• Biological replicates: Analyze at least three independent biological samples

• Standard curve: For ELISA, generate a standard curve using recombinant protein

• Dynamic range: Ensure signals fall within the linear range of detection

• Normalization: Use appropriate housekeeping proteins or total protein staining for normalization

• Statistical analysis: Apply appropriate statistical tests based on experimental design

The reliability metrics for antibody-based assays typically include assessments of:

• Intra-assay coefficient of variation (CV): Typically <10% for reliable assays

• Inter-assay CV: Typically <15% for reliable assays

• Spike and recovery tests: Expecting 90-110% recovery

How can reproducibility issues with DER2.2 Antibody be addressed in long-term research projects?

To ensure reproducibility across extended research timelines, consider strategies similar to those used for other research antibodies :

• Antibody validation documentation: Maintain detailed records of validation experiments

• Reference sample banking: Store reference samples that can be used to validate new antibody batches

• Batch purchasing: When possible, purchase sufficient antibody from the same batch for the entire project

• Standardized protocols: Document detailed protocols including all buffer compositions, incubation times, and temperatures

• Positive control inclusion: Always include the same positive control sample across experiments

• Image acquisition standardization: Use consistent imaging parameters and equipment settings

How do advances in antibody technology impact the future use of plant antibodies like DER2.2?

Emerging antibody technologies similar to those described for other research areas may inform future DER2.2 Antibody development:

• Recombinant antibody production: Moving from animal-raised polyclonal antibodies to recombinant monoclonal antibodies for improved consistency

• Fragment antibody formats: Smaller antibody fragments may improve tissue penetration in certain applications

• AI-based antibody design: Computational approaches to predict optimal epitopes and antibody structures

• Direct labeling strategies: Primary antibodies directly conjugated with fluorophores or enzymes to simplify workflows

• Enhanced validation standards: More rigorous validation requirements using genetic knockout controls and multiple techniques

How might DER2.2 Antibody be integrated with -omics approaches in plant research?

Based on integrative approaches used in other fields , researchers could consider:

• Immunoprecipitation coupled with mass spectrometry: Identify DER2.2 interaction partners under different conditions

• ChIP-seq applications: If DER2.2 has DNA-binding properties or associates with chromatin-binding proteins

• Spatial proteomics: Combine with tissue clearing and advanced microscopy for 3D localization studies

• Single-cell applications: Adaptation for single-cell protein analysis in plant tissues

• Integration with transcriptomics: Correlate protein abundance with transcript levels across conditions

• Systems biology approaches: Place DER2.2 function within broader signaling networks